Emergent BioSolutions falls after reporting downbeat quarterly revenue

Emergent BioSolutions

03/03/2025 22:10

** Shares of Emergent BioSolutions EBS.N fall 12.5% to $5.98 in extended trading, the lowest since September

** Company reported a decline in its fourth-quarter revenue, which stood at $194.7 million, down from $276.6 million a year ago

** On an adjusted basis, company reported EPS of 5 cents, vs a loss of 77 cents previous year

** Company is moving forward with turnaround activities, a critical phase in its multi-year transformation plan - EBS

** Company's shares up 298.3% in 2024

 (Reporting by Kritika Lamba in Bengaluru)

 ((Kritika.Lamba@thomsonreuters.com))